Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Recent Merck Frosst patent claims new GPR105 antagonists for type 2 diabetes and obesity

Feb. 11, 2009

Priligy receives first regulatory approvals for premature ejaculation

Feb. 10, 2009

Novel 11beta-HSD1 inhibitors imparted by Taisho for type 2 diabetes

Feb. 10, 2009

Oramed completes proof-of-concept study of ORMD-0802

Feb. 9, 2009

Trial aimed at regenerating insulin-producing capacity gets FDA approval

Feb. 6, 2009

Transition Therapeutics completes patient enrollment of phase II TT-223 study

Feb. 6, 2009

FDA Advisory Committee favors approval of DX-88 for hereditary angioedema

Feb. 5, 2009

Human ProIslet Peptide stimulates islet neogenesis

Feb. 5, 2009

Warner Chilcott acquires NexMed's alprostadil for erectile dysfunction

Feb. 5, 2009

Medivir selects MIV-710 as a candidate drug for osteoporosis and osteoarthritis

Feb. 5, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...